Research reviews the therapeutic potential of cannabidiol (CBD) in treating cognitive impairments, highlighting positive effects in some trials while emphasizing the need for more comprehensive studies.
Vaccinex plans Nasdaq exit as Alzheimer market pressure grows – Pharmaceutical Technology
Vaccinex’s lead asset is being evaluated in neurodegenerative and oncological indications. Image credit: Shutterstock/interstid. Despite reporting positive Phase II results for its lead candidate last